Interleukin-13 in systemic sclerosis: Relationship to nailfold capillaroscopy abnormalities

Clinical Rheumatology

Volumn 22, Issue 2, 2003, Pages 102-106

  Riccieri, V ^a   Rinaldi, T ^a   Spadaro, A ^a   Scrivo, R ^a   Ceccarelli, F ^a   Di Franco, M ^a   Taccari, E ^a   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Interleukin 13; Nailfold capillaroscopy; Systemic sclerosis

Indexed keywords

INTERLEUKIN 13;

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD ANALYSIS; CAPILLAROSCOPY; CAPILLARY DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGER NAIL; HUMAN; IMMUNOLOGY; MALE; MICROANGIOPATHY; MORPHOLOGY; NAIL DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; SYSTEMIC SCLEROSIS; VEIN DIAMETER;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-13; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; VASCULAR DISEASES;

EID: 0038648778     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-0684-z     Document Type: Article

References (23)

1. LeRoy EC (1992) Systemic sclerosis. In: McCarty DJ, Koopman WJ, (eds) Arthritis and allied conditions, 12th edn. Philadelphia: Lea & Febiger, pp 1293-1299
2. Sato S (1999) Abnormalities of adhesion molecules and chemokines in scleroderma. Curr Opin Rheumatol 11: 503-507
3. Minty A et al (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248-250
4. Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15: 19-26
5. Halloran MM, Haskell CJ, Woods JM, Hosaka S, Koch AE (1997) Interleukin-13 is an endothelial chemotaxin. Pathobiology 65: 287-292
6. Oriente A, Fedarko NS, Pacocha SE, Huang S, Lichtenstein LM, Essayan DM (2000) Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 292: 988-994
7. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B (1998) IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 10: 1421-1433
8. Denton CP, Shiwen X, Welsh K, Pearson JD, Black CM (1996) Scleroderma fibroblast phenotype is modulated by endothelial cell co-culture. J Rheumatol 23: 633-638
9. Spadaro A, Rinaldi T, Riccieri V, Taccari E, Valesini G (2002) Interleukin-13 in autoimmune rheumatic diseases: relationship with autoantibody profile. Ann Rheum Dis 20: 213-216
10. Hasegawa M et al (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10 and IL-13 in patients with systemic sclerosis. J Rheumatol 24: 328-332
11. Maricq HR, LeRoy EC, D'Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23: 183-189
12. Masi AT, Medsger TA, Rodnan GP et al (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581-590
13. Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31: 196-203
14. Kabasakal Y, Elvins DM, Ring EFJ, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55: 507-512
15. Maricq HR (1981) Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24: 1159-1165
16. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC (1983) Microvascular abnormalities as possible predictors of disease subset in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1: 195-205
17. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27: 155-160
18. Lee P, Leung FYK, Alderice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semi-quantitative assessment. J Rheumatol 10: 930-938
19. Andreda LEC, Gabriel Aj, Assad RL, Ferrari AJL, Atra E (1990) Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 20: 21-31
20. Bukhari M, Hollis S, Moore T, Jayson V, Herrick AL (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology 39: 506-512
21. Isomaki P, Luukkainen R, Toivanen P, Punnonen J (1996) The presence of interleukin 13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 39: 1693-1702
22. Valentini G, Della Rossa A, Bombardieri S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60: 592-598
23. Lanzetti LS, Joyal F, Raynauld JP et al (20dl) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum; 735-738